Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Introduction: High spontaneous activity of the renin–angiotensin system (RAS) results in more pronounced cognitive impairment and more prolonged QTc interval during hypoglycaemia in type 1 diabetes. We tested whether angiotensin II receptor blockade improves cerebral and cardiovascular function during hypoglycaemia. Methods: Nine patients with type 1 diabetes and high spontaneous RAS activity were included in a double-blind, randomised, cross-over study on the effect of angiotensin II receptor antagonist (candesartan 32 mg) or placebo for one week on cognitive function, cardiovascular parameters, hormonal counter-regulatory response, substrate mobilisation, and symptoms during hypoglycaemia induced by two hyperinsulinaemic, hypoglycaemic clamps. Results: Compared to placebo, candesartan did neither change performance of the cognitive tests nor the EEG at a plasma glucose concentration of 2.6±0.2 mmol/l. During candesartan treatment, the QT interval in the ECG was not affected. No effect of candesartan was observed in the hormonal counter-regulatory responses, in substrate concentrations, or in symptom scores. A 36% reduced glucose infusion rate during hypoglycaemia with candesartan was observed. Conclusion: In conclusion candesartan has no effect on cerebral function during mild experimental hypoglycaemia in subjects with type 1 diabetes and high RAS activity. Candesartan may reduce glucose utilisation or increase endogenous glucose production during hypoglycaemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with our results, previous studies showed no impact of angiotensin II receptor blockade on hypoglycemia-induced QTc prolongation (26).”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [26]
Citations
Cites
A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary
Selnes, O. A. (1991) · Neurology · doi:10.1212/wnl.41.11.1856-a · Cited by 2,252
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“55 Stroop word, items completed 104 (17) 86 (16) <0.”
Bolli, G., Feo, P. D., Compagnucci, P., Cartechini, M. G., Angeletti, G., Santeusanio, F., Brunetti, P., & Gerich, J. E. (1983) · Diabetes · doi:10.2337/diab.32.2.134 · Cited by 433
Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes
Cryer, P. E. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3592 · Cited by 401
Pedersen‐Bjergaard, U., Pramming, S., Heller, S. R., Wallace, T. M., Rasmussen, Å. K., Jørgensen, H. V., Matthews, D. R., Hougaard, P., & Thorsteinsson, B. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.482 · Cited by 371 · cited 2×
“05 NA Trail-making B test, s 33 (9) 44 (25) 0.”
Self-citationGill, G. V., Woodward, A., Casson, I. F., & Weston, P. J. (2009) · Diabetologia · doi:10.1007/s00125-008-1177-7 · Cited by 294 · cited 1×
“Heart rate, beats/min 72 (13) 73 (14) 0.”
Saavedra, J. M., Sánchez-Lemus, E., & Benicky, J. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.10.001 · Cited by 260
Recall of severe hypoglycaemia and self‐estimated state of awareness in type 1 diabetes
Pedersen‐Bjergaard, U., Pramming, S., & Thorsteinsson, B. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.377 · Cited by 240 · cited 1×
“7) AT2R AG genotype (AA/AG/GG) (n) 8/1/0 Serum ACE activity (U/l) 49 (21) Angiotensinogen (nmol/l)b 1133 (183)”
Self-citationPedersen‐Bjergaard, U., Agerholm-Larsen, B., Pramming, S., Hougaard, P., & Thorsteinsson, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04405-6 · Cited by 141 · cited 2×
“Number of participants (females) (n) 9 (1) Age (years) 56 (9.”
MethodSelf-citationNishimura, Y., Ito, T., Hoe, K., & Saavedra, J. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02377-5 · Cited by 136
Research works printed but not linked: 3
- Heller SR, 2002, Diabetes Nutr Metab, 15, 461
- Strauss E, 2006, A compendium of neuropsychological tests, 477
- Holst JJ, 1983, Diabetologia, 24, 359
Cited by
Fitzpatrick, C., Chatterjee, S., Seidu, S., Bodicoat, D. H., Ng, G. A., Davies, M. J., & Khunti, K. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13348 · Cited by 57
Hypoglycaemia and cardiac arrhythmias in diabetes
Andersen, A., Jørgensen, P. G., Knop, F. K., & Vilsbøll, T. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820911803 · Cited by 54
Hypoglycemia-Induced Changes in the Electroencephalogram: An Overview
Blaabjerg, L., & Juhl, C. B. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816659744 · Cited by 34
Andreasen, C. R., Andersen, A., Hagelqvist, P. G., Maytham, K. B., Lauritsen, J. V., Engberg, S., Faber, J. O., Pedersen‐Bjergaard, U., Knop, F. K., & Vilsbøll, T. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15005 · Cited by 15
“1%]), their body mass index was 26 (23-27) kg/m(2), and they had a diabetes duration of 23 (7-38) years.”
BackgroundSelf-citationHagelqvist, P. G., Andersen, A., Maytham, K. B., Andreasen, C. R., Engberg, S., Lindhardt, T. B., Faber, J. O., Holst, J. J., Forman, J. L., Pedersen‐Bjergaard, U., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14964 · Cited by 6
Self-citation
Metadata
- Authors
- Færch, L. H., Thorsteinsson, B., Tarnow, L., Holst, J. J., Kjær, T., Kanters, J., Larroude, C., Dela, F., & Pedersen-Bjergaard, U.
- Affiliations
- Nordsjællands Hospital (DK)
- University of Copenhagen (DK)
- Aarhus University (DK)
- Copenhagen University Hospital (DK)
- Department of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital – Frederikssund, Denmark
- Department of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital – Hillerød, Denmark
- Corresponding author
- Færch, Louise H
- Venue
- Journal of the Renin-Angiotensin-Aldosterone System
- Publisher
- SAGE Publications
- Published
- 2014-07-27
- Volume
- 16
- Issue
- 4
- Pages
- 1036-1045
- ISSN
- 1470-3203 (ISSN-L)
- 1752-8976
- OpenAlex
- W2131234584
- Cited by
- 8
- References
- 35
- Citations by year
- 2025: 2 · 2023: 3 · 2020: 1 · 2018: 1 · 2016: 1
- FWCI
- 0.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of the Renin-Angiotensin-Aldosterone System (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, hypoglycemia, angiotensin II receptor blockade, candesartan, renin-angiotensin system, cognitive function, QTc interval, counterregulatory response, hypoglycaemic symptoms, glucose infusion rate, endogenous glucose production
- MeSH terms
- Blood Glucose, Brain, Cardiovascular System, Cognition, Diabetes Mellitus, Type 1, Electrocardiography, Electroencephalography, Female, Humans, Hypoglycemia, Male, Middle Aged, Receptors, Angiotensin, Glucose Clamp Technique, Angiotensin Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes. https://app.cochat.ai/papers/10.1177/1470320314529356
- The paper
- Færch, L. H., Thorsteinsson, B., Tarnow, L., Holst, J. J., Kjær, T., Kanters, J., Larroude, C., Dela, F., & Pedersen-Bjergaard, U. (2015). Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes. Journal of the Renin-Angiotensin-Aldosterone System. https://doi.org/10.1177/1470320314529356
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.